{{Rsnum
|rsid=12510549
|Chromosome=4
|position=10274843
|Orientation=plus
|GMAF=0.1736
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 1.8 | 38.1 | 60.2
| HCB | 0.7 | 24.1 | 75.2
| JPT | 0.9 | 27.4 | 71.7
| YRI | 2.0 | 21.1 | 76.9
| ASW | 1.8 | 24.6 | 73.7
| CHB | 0.7 | 24.1 | 75.2
| CHD | 0.9 | 27.8 | 71.3
| GIH | 1.0 | 13.9 | 85.1
| LWK | 4.5 | 21.8 | 73.6
| MEX | 6.9 | 36.2 | 56.9
| MKK | 0.6 | 16.8 | 82.6
| TSI | 4.9 | 27.5 | 67.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19877038
|Title=Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand M&#x101;ori, Pacific Island, and Caucasian case-control sample sets
}}

{{PMID Auto
|PMID=18398472
|Title=Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
|OA=1
}}

{{PMID Auto
|PMID=18487473
|Title=Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.
|OA=1
}}

{{PMID Auto
|PMID=18606621
|Title=SLC2A9--a fructose transporter identified as a novel uric acid transporter.
|OA=1
}}

{{PMID Auto
|PMID=20053405
|Title=Sex and age interaction with genetic association of atherogenic uric acid concentrations.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}